Compare $MDXG vs $PRME | Chartloom

Compare

$MDXG vs $PRME

MiMedx Group Inc · Prime Medicine Inc

MDXG

MiMedx Group Inc

PRME

Prime Medicine Inc

Compare $MDXG vs $PRME

Comparing MiMedx Group Inc and Prime Medicine Inc

MDXGMiMedx Group Inc

PRMEPrime Medicine Inc

MDXGMiMedx Group Inc

Market cap

$681M

P/E (TTM)

110.63x

Forward P/E (NTM)

130.81x

Forward P/S (NTM)

2.16x

Rev growth (TTM)

-2.4%

YTD performance

-27.9%

52W performance

-34.2%

FCF yield

6.5%

PRMEPrime Medicine Inc

Market cap

$721M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

126.79x

Rev growth (TTM)

-17.9%

YTD performance

13.0%

52W performance

-38.1%

FCF yield

-21.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MDXG

PRME

Detailed metrics comparison

MDXG

MiMedx Group Inc

PRME

Prime Medicine Inc

Market Cap

MDXG$681M

PRME$721M

Enterprise Value

MDXG$562M

PRME$673M

Price

MDXG$4.67

PRME$3.99

P/E Ratio

MDXG110.63x

PRMEN/A

P/S Ratio

MDXG1.92x

PRME176.94x

EV/Sales

MDXG1.58x

PRME165.29x

EV/EBITDA

MDXG27.54x

PRME0.00x

P/B Ratio

MDXG3.10x

PRME13.58x

P/FCF Ratio

MDXG15.32x

PRMEN/A

EV/FCF

MDXG12.65x

PRME-4.29x

PEG Ratio

MDXGN/A

PRMEN/A

Forward P/E (NTM)

MDXG130.81x

PRMEN/A

Forward P/S (NTM)

MDXG2.16x

PRME126.79x

Revenue (TTM)

MDXG$355M

PRME$4M

Revenue Growth (YoY)

MDXG-2.4%

PRME-17.9%

Forward Rev Growth

MDXG22.1%

PRME22.7%

Gross Margin (TTM)

MDXG78.8%

PRME0.0%

Operating Margin (TTM)

MDXG2.5%

PRME0.0%

EBITDA Margin (TTM)

MDXG5.7%

PRME-4643.3%

Net Margin (TTM)

MDXG1.8%

PRME-4613.1%

FCF Margin (TTM)

MDXG12.5%

PRME-3850.9%

Net Income (TTM)

MDXG$6M

PRME$-188M

FCF (TTM)

MDXG$44M

PRME$-157M

EPS (TTM)

MDXG$0.04

PRME-$1.06

ROE (TTM)

MDXG2.6%

PRME-18827.0%

ROA (TTM)

MDXG2.0%

PRME-5911.0%

ROIC (TTM)

MDXG2.4%

PRME-18827.0%

Cash

MDXG$136M

PRME$47M

Debt

MDXG$17M

PRME$0

Net Cash/Debt

MDXG$119M

PRME$47M

Current Ratio (TTM)

MDXG5.33x

PRME3.05x

Quick Ratio (TTM)

MDXG4.79x

PRME3.01x

Debt/Equity (TTM)

MDXG0.08x

PRME0.00x

Debt/Assets (TTM)

MDXG0.0%

PRME0.0%

Interest Coverage (TTM)

MDXGN/A

PRMEN/A

Net Debt/EBITDA (TTM)

MDXG0.00x

PRME0.00x

Beta

MDXG1.20

PRME2.35

52W Performance

MDXG-34.2%

PRME-38.1%

YTD Performance

MDXG-27.9%

PRME13.0%

% from 52W High

MDXG-41.4%

PRME-40.0%

% from 52W Low

MDXG54.1%

PRME49.4%

Asset Turnover (TTM)

MDXG1.14x

PRME0.01x

FCF Yield (TTM)

MDXG6.5%

PRME-21.8%

Earnings Yield (TTM)

MDXG0.9%

PRME-26.1%

Dividend Yield (TTM)

MDXGN/A

PRMEN/A

Rule of 40

MDXG10.1

PRME-3,868.8

EV/GP/RG

MDXG0.09

PRMEN/A

Ticker research

View MDXG research View PRME research

Metric	MDXG MiMedx Group Inc	PRME Prime Medicine Inc
Market & Valuation
Market Cap	$681M	$721M
Enterprise Value	$562M	$673M
Price	$4.67	$3.99
P/E Ratio	110.63x	N/A
P/S Ratio	1.92x	176.94x
EV/Sales	1.58x	165.29x
EV/EBITDA	27.54x	0.00x
P/B Ratio	3.10x	13.58x
P/FCF Ratio	15.32x	N/A
EV/FCF	12.65x	-4.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	130.81x	N/A
Forward P/S (NTM)	2.16x	126.79x
Revenue & Growth
Revenue (TTM)	$355M	$4M
Revenue Growth (YoY)	-2.4%	-17.9%
Forward Rev Growth	22.1%	22.7%
Profitability
Gross Margin (TTM)	78.8%	0.0%
Operating Margin (TTM)	2.5%	0.0%
EBITDA Margin (TTM)	5.7%	-4643.3%
Net Margin (TTM)	1.8%	-4613.1%
FCF Margin (TTM)	12.5%	-3850.9%
Net Income (TTM)	$6M	$-188M
FCF (TTM)	$44M	$-157M
EPS (TTM)	$0.04	-$1.06
ROE (TTM)	2.6%	-18827.0%
ROA (TTM)	2.0%	-5911.0%
ROIC (TTM)	2.4%	-18827.0%
Financial Health
Cash	$136M	$47M
Debt	$17M	$0
Net Cash/Debt	$119M	$47M
Current Ratio (TTM)	5.33x	3.05x
Quick Ratio (TTM)	4.79x	3.01x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	2.35
52W Performance	-34.2%	-38.1%
YTD Performance	-27.9%	13.0%
% from 52W High	-41.4%	-40.0%
% from 52W Low	54.1%	49.4%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.01x
FCF Yield (TTM)	6.5%	-21.8%
Earnings Yield (TTM)	0.9%	-26.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	10.1	-3,868.8
EV/GP/RG	0.09	N/A
Ticker research	View MDXG research	View PRME research

Valuation

P/E Ratio

MDXG

110.63x

P/S Ratio

MDXG

1.92x

PRME

176.94x

EV/FCF

PRME

-4.29x

MDXG

12.65x

Growth & revenue

Revenue Growth TTM

MDXG

-2.4%

PRME

-17.9%

Forward Revenue Growth

PRME

22.7%

MDXG

22.1%

Profitability & performance

Gross Margin

MDXG

78.8%

PRME

0.0%

ROE

MDXG

2.6%

PRME

-18827.0%

FCF Yield %

MDXG

6.5%

PRME

-21.8%

52-Week Performance

MDXG

-34.2%

PRME

-38.1%

Detailed metrics comparison

MDXG

MiMedx Group Inc

PRME

Prime Medicine Inc

Market Cap

MDXG$681M

PRME$721M

Enterprise Value

MDXG$562M

PRME$673M

Price

MDXG$4.67

PRME$3.99

P/E Ratio

MDXG110.63x

PRMEN/A

P/S Ratio

MDXG1.92x

PRME176.94x

EV/Sales

MDXG1.58x

PRME165.29x

EV/EBITDA

MDXG27.54x

PRME0.00x

P/B Ratio

MDXG3.10x

PRME13.58x

P/FCF Ratio

MDXG15.32x

PRMEN/A

EV/FCF

MDXG12.65x

PRME-4.29x

PEG Ratio

MDXGN/A

PRMEN/A

Forward P/E (NTM)

MDXG130.81x

PRMEN/A

Forward P/S (NTM)

MDXG2.16x

PRME126.79x

Revenue (TTM)

MDXG$355M

PRME$4M

Revenue Growth (YoY)

MDXG-2.4%

PRME-17.9%

Forward Rev Growth

MDXG22.1%

PRME22.7%

Gross Margin (TTM)

MDXG78.8%

PRME0.0%

Operating Margin (TTM)

MDXG2.5%

PRME0.0%

EBITDA Margin (TTM)

MDXG5.7%

PRME-4643.3%

Net Margin (TTM)

MDXG1.8%

PRME-4613.1%

FCF Margin (TTM)

MDXG12.5%

PRME-3850.9%

Net Income (TTM)

MDXG$6M

PRME$-188M

FCF (TTM)

MDXG$44M

PRME$-157M

EPS (TTM)

MDXG$0.04

PRME-$1.06

ROE (TTM)

MDXG2.6%

PRME-18827.0%

ROA (TTM)

MDXG2.0%

PRME-5911.0%

ROIC (TTM)

MDXG2.4%

PRME-18827.0%

Cash

MDXG$136M

PRME$47M

Debt

MDXG$17M

PRME$0

Net Cash/Debt

MDXG$119M

PRME$47M

Current Ratio (TTM)

MDXG5.33x

PRME3.05x

Quick Ratio (TTM)

MDXG4.79x

PRME3.01x

Debt/Equity (TTM)

MDXG0.08x

PRME0.00x

Debt/Assets (TTM)

MDXG0.0%

PRME0.0%

Interest Coverage (TTM)

MDXGN/A

PRMEN/A

Net Debt/EBITDA (TTM)

MDXG0.00x

PRME0.00x

Beta

MDXG1.20

PRME2.35

52W Performance

MDXG-34.2%

PRME-38.1%

YTD Performance

MDXG-27.9%

PRME13.0%

% from 52W High

MDXG-41.4%

PRME-40.0%

% from 52W Low

MDXG54.1%

PRME49.4%

Asset Turnover (TTM)

MDXG1.14x

PRME0.01x

FCF Yield (TTM)

MDXG6.5%

PRME-21.8%

Earnings Yield (TTM)

MDXG0.9%

PRME-26.1%

Dividend Yield (TTM)

MDXGN/A

PRMEN/A

Rule of 40

MDXG10.1

PRME-3,868.8

EV/GP/RG

MDXG0.09

PRMEN/A

Ticker research

View MDXG research View PRME research

Metric	MDXG MiMedx Group Inc	PRME Prime Medicine Inc
Market & Valuation
Market Cap	$681M	$721M
Enterprise Value	$562M	$673M
Price	$4.67	$3.99
P/E Ratio	110.63x	N/A
P/S Ratio	1.92x	176.94x
EV/Sales	1.58x	165.29x
EV/EBITDA	27.54x	0.00x
P/B Ratio	3.10x	13.58x
P/FCF Ratio	15.32x	N/A
EV/FCF	12.65x	-4.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	130.81x	N/A
Forward P/S (NTM)	2.16x	126.79x
Revenue & Growth
Revenue (TTM)	$355M	$4M
Revenue Growth (YoY)	-2.4%	-17.9%
Forward Rev Growth	22.1%	22.7%
Profitability
Gross Margin (TTM)	78.8%	0.0%
Operating Margin (TTM)	2.5%	0.0%
EBITDA Margin (TTM)	5.7%	-4643.3%
Net Margin (TTM)	1.8%	-4613.1%
FCF Margin (TTM)	12.5%	-3850.9%
Net Income (TTM)	$6M	$-188M
FCF (TTM)	$44M	$-157M
EPS (TTM)	$0.04	-$1.06
ROE (TTM)	2.6%	-18827.0%
ROA (TTM)	2.0%	-5911.0%
ROIC (TTM)	2.4%	-18827.0%
Financial Health
Cash	$136M	$47M
Debt	$17M	$0
Net Cash/Debt	$119M	$47M
Current Ratio (TTM)	5.33x	3.05x
Quick Ratio (TTM)	4.79x	3.01x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	2.35
52W Performance	-34.2%	-38.1%
YTD Performance	-27.9%	13.0%
% from 52W High	-41.4%	-40.0%
% from 52W Low	54.1%	49.4%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.01x
FCF Yield (TTM)	6.5%	-21.8%
Earnings Yield (TTM)	0.9%	-26.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	10.1	-3,868.8
EV/GP/RG	0.09	N/A
Ticker research	View MDXG research	View PRME research